Sponsored Content

Study: Pycnogenol® Helps Relieve and May Prevent Symptoms of Restless Legs Syndrome

14 Nov 2022

Promising new clinical research offers a trusted natural option for those who suffer from disruptive leg sensations that are often missed and dismissed in diagnosis.

GENEVA, Switzerland – New scientific findings offer hope and a natural solution to those who suffer from sensations of crawling, pulling, throbbing, aching and itching in the legs, often resulting in sleep disruption and the uncontrollable urge to move. Restless Legs Syndrome (RLS) impacts nearly 10 percent of the U.S. population and can lead to other health concerns. A new study found Pycnogenol® French maritime pine bark extract, a leading natural anti-inflammatory and circulation booster, to significantly relieve and prevent symptoms associated with Restless Legs Syndrome.

“Restless Legs Syndrome is often missed or dismissed in diagnosis, but it’s a real health condition often rooted in microcirculation. Many patients feel helpless and unheard because the symptoms seem to be exaggerated or imagined. It’s not in your head – it’s in your legs, and this research shows there are steps you can take with a powerful natural ingredient that may help you feel better,” says author and renowned natural physician, Dr. Fred Pescatore.

Frustrating symptoms can begin at any age and worsen. Most who suffer from this condition feel sensations of crawling, pulling and throbbing after long periods of sitting or lying down, such as sleeping or sitting at a desk. Moving the legs typically temporarily relieves the discomfort, but the sensations can reoccur after movement stops. Those who have Restless Legs Syndrome can also suffer from poor sleep quality, fatigue and higher stress levels, which can impact other aspects of daily life.

The study, published in Panminerva Medica, tested 45 subjects with Restless Legs Syndrome. Twenty-one (21) subjects supplemented with 150 mg of Pycnogenol® per day, while another 24 subjects followed a standard management routine in the control group. After four weeks, subjects in the Pycnogenol® group showed significant improvement in all prominent symptoms of Restless Legs Syndrome, including:

Study: Pycnogenol® Helps Relieve and May Prevent Symptoms of Restless Legs Syndrome
Pycnogenol® Helps Relieve and May Prevent Symptoms of Restless Legs Syndrome

Research indicates that as many as 22 percent of those with Restless Legs Syndrome also have venous insufficiency. While additional research is needed to determine the relationship between Restless Legs Syndrome and edema, this study found that 81 percent of subjects in the Pycnogenol® group improved their status of minimal edema.

Additionally, after four weeks, the need for pain managements was significantly reduced for those in the Pycnogenol® group.

“Even when Restless Legs Syndrome is properly diagnosed, medication to treat the condition includes pharmaceuticals that increase dopamine in the brain, resulting in side effects like nausea and sleepiness. Opioids or narcotic medications may be used to relieve more severe symptoms and can be extremely addictive,” says Dr. Pescatore.

“Pycnogenol® is an all-natural solution. Decades of research and global market availability show this circulation booster is safe and effective and is especially recognized as an ingredient at the forefront of naturally improving blood circulation. This study now shows its effects specifically on symptoms related to Restless Legs Syndrome,” said Dr. Pescatore.

About Pycnogenol® 

Pycnogenol® is a natural plant extract originating from the bark of the maritime pine that grows along the coast of southwest France and is found to contain a unique combination of procyanidins, bioflavonoids and phenolic acids, which offer extensive natural health benefits. The extract has been widely studied for the past 40 years and has more than 450 published studies and review articles ensuring safety and efficacy as an ingredient. Today, Pycnogenol® is available in more than 1,000 dietary supplements and health products worldwide. For more information, visit www.pycnogenol.com.   

About Horphag Research 

Horphag Research is the exclusive worldwide distributor for Pycnogenol® (pic-noj-en-all) brand French maritime pine bark extract. Pycnogenol® is a registered trademark of Horphag Research. For its patented ingredient, Pycnogenol®, Horphag Research has been awarded the Frost & Sullivan Excellence in Research Award, Nutraceutical Business & Technology Safety & Quality Award, SupplySide West Scientific Excellence Award and The American Botanical Council's Tyler Research Award. Horphag Research has the exclusive rights to market and sell Pycnogenol® worldwide and benefits from more than 40 years of scientific research assuring the safety and efficacy of Pycnogenol® as a dietary supplement. 

Read More

Related news

PharmaLinea’s iron supplement delivers improvements in  hemoglobin comparable to ferrous sulfate with fewer side  effects

PharmaLinea’s iron supplement delivers improvements in hemoglobin comparable to ferrous sulfate with fewer side effects

23 Feb 2026

PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.

Read more 
LomaChelateX® – power in magnesium bisglycinate

LomaChelateX® – power in magnesium bisglycinate

12 Feb 2026

Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.

Read more 
Fucoidan leader reports record production

Fucoidan leader reports record production

22 Jan 2026

The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.

Read more 
India Honours Ashwagandha with Commemorative  Postal Stamp at WHO Global Summit

India Honours Ashwagandha with Commemorative Postal Stamp at WHO Global Summit

6 Jan 2026

HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...

Read more 
PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

22 Dec 2025

PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...

Read more 
FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

11 Dec 2025

Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...

Read more 
dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

11 Dec 2025

Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025  dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...

Read more 
Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

11 Dec 2025

Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...

Read more 
Fucoidan specialist takes out top international health award

Fucoidan specialist takes out top international health award

4 Dec 2025

Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.

Read more 
Prayon inaugurates its new SHMP production unit in Engis

Prayon inaugurates its new SHMP production unit in Engis

1 Dec 2025

Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market

Read more